GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: CCG 1423 | CCG1423
Compound class:
Synthetic organic
Comment: CCG-1423 inhibits RhoA transcriptional signaling via an unknown mechanism of action but is tool compound for the disruption of transcriptional responses of the Rho pathway in cancer.
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| N-[1-[(4-chlorophenyl)amino]-1-oxopropan-2-yl]oxy-3,5-bis(trifluoromethyl)benzamide |
Synonyms ![]() |
| CCG 1423 | CCG1423 |
Database Links ![]() |
|
| CAS Registry No. | 285986-88-1 (source: Supplier) |
| GtoPdb PubChem SID | 178103371 |
| PubChem CID | 2726015 |
| Search Google for chemical match using the InChIKey | DSMXVSGJIDFLKP-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | DSMXVSGJIDFLKP |
| UniChem Compound Search for chemical match using the InChIKey | DSMXVSGJIDFLKP-UHFFFAOYSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | DSMXVSGJIDFLKP-UHFFFAOYSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖|
CCG-1423 (links to external site)
Cat. No. HY-13991 |